Please login to the form below

Not currently logged in
Email:
Password:

Lilly strengthens team with in-house promotions

And two senior leaders retire

Eli Lilly and Company has strengthened its senior leadership team by promoting several of its employees into executive roles.

Josh Smiley, who has held various positions since starting in June 2000, has been promoted to senior vice president and chief financial officer, and will also become a member of the executive committee as of 1 January 2018.

He takes up the position following his predecessor’s - Derica Rice - announcement of retirement at the end of the year.

Dan Skovronsky has also been promoted to a senior vice president role, taking the helm of its science and technology business in addition to becoming president of Lilly Research Labs.

Skovronsky will also become a member of the executive committee as of 1 June 2018.

Additionally, Myles O’Neil has been promoted to senior vice president and president of manufacturing operations and will become a member of the executive committee.

Furthermore, Aarti Shah, Lilly’s current senior vice president and chief information officer, has been named an executive officer and will join the pharma group's executive committee, directly reporting to chief executive officer David Ricks.

Ricks said: “Joining our executive team are individuals who have the experience, expertise and leadership skills to build on our momentum of innovation driven volume growth.

“Importantly, this team will help us maintain focus as we work to bring forward new medicines in diabetes, cancer, immunology, neurodegeneration and pain.”

In addition to the appointments, Maria Crowe, president of manufacturing operations will retire in December 2017 after 35 years of service.

Lilly’s current executive vice president, Jan Lundberg, is also set to retire at the end of May 2018 following eight years with Lilly.

13th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics